Cellular Immunotherapy for Septic Shock: A Phase I Trial
Clinical trial NCT02421484 · COMPLETED
Trial details
- NCT number
- NCT02421484
- Sponsor
- Ottawa Hospital Research Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.